JMP Securities Downgrades Cortexyme to Market Perform
JMP Securities analyst Jason Butler downgrades Cortexyme (NASDAQ:CRTX) from Market Outperform to Market Perform.
32 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Exela Technologies, Inc. (NASDAQ: XELA) rose 32% to $0.7262 after the company announced a share buyback of up to 100 million shares of common stock at $1 per share through an exchange offer of new notes.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 34 stocks hit new 52-week lows.
Why Cortexyme Shares Are Falling
Cortexyme Inc (NASDAQ: CRTX) shares are trading lower by 29% at $6.41 Wednesday morning after the company announced a clinical hold on Atuzaginstat's Investigational New Drug application.
Cortexyme Announces Clinical Hold On Atuzaginstat’s Investigational New Drug Application
Cortexyme, Inc. (NASDAQ:CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer's and other degenerative diseases, today announced that the company received a letter from the U.S. Food and Drug
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.